ERG and prostate carcinoma: Overexpression of ERG is thought to result in increased proliferation, invasiveness and motility of prostate cancer cells [18-20,30], whereas protein 4.1B has been shown to oppose invasiveness and metastasis of prostate cancer cells [5,7] and EHM2 to modulate adhesion of prostate cancer cells [10].